Schedule 13G ownership disclosure

BIOCRYST PHARMACEUTICALS INC

Security class unavailable · CUSIP: 09058V103

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
8,382,900
Percent of class
5.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000899140-20-000183
Form type
SC 13G/A
Filer
BIOCRYST PHARMACEUTICALS INC
CIK
CIK 882796
Filed
Feb 14, 2020
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub